Cardiovascular Impact of Near Complete Estrogen Deprivation in Premenopausal Women with Breast Cancer: The CROWN Study

Mortality After Late Breast Cancer Recurrence in Denmark

(2022) Rikke Nørgaard Pedersen et al.   JOURNAL OF CLINICAL ONCOLOGY

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

(2021) H.J. Burstein et al.   ANNALS OF ONCOLOGY

Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer

(2020) Farzin Khosrow-Khavar et al.   CIRCULATION

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

(2018) Prudence A. Francis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic Value of Quantitative Stress Perfusion Cardiac Magnetic Resonance

(2018) Eva C. Sammut et al.   JACC-Cardiovascular Imaging

Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review

(2018) Anthony Matthews et al.   BMJ-British Medical Journal

Coronary computed tomographic imaging in women: An expert consensus statement from the Society of Cardiovascular Computed Tomography

(2018) Quynh A. Truong et al.   Journal of Cardiovascular Computed Tomography

Risk of Heart Disease in Breast Cancer Patients Receiving Estrogen-Deprivation Therapy

(2017) Abigail Sindzinski   JNCI-Journal of the National Cancer Institute

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

(2017) Hongchao Pan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage

(2017) Jemma Mytton et al.   BMJ-British Medical Journal

2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology

(2017) Harvey S. Hecht et al.   Journal of Cardiovascular Computed Tomography

Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage

(2017) Jemma Mytton et al.   BMJ-British Medical Journal

Risk of Heart Disease in Breast Cancer Patients Receiving Estrogen-Deprivation Therapy

(2017) Abigail Sindzinski   JNCI-Journal of the National Cancer Institute

Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study

(2016) Walter A. Rocca et al.   MAYO CLINIC PROCEEDINGS

Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol

(2016) Howard N. Hodis et al.   NEW ENGLAND JOURNAL OF MEDICINE

SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines Committee

(2016) Suhny Abbara et al.   Journal of Cardiovascular Computed Tomography

Perfecting Breast-Cancer Treatment — Incremental Gains and Musculoskeletal Pains

(2015) Dawn L. Hershman   NEW ENGLAND JOURNAL OF MEDICINE

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

(2015) Prudence A. Francis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased Cardiovascular Stiffness and Impaired Age-related Functional Status

(2014) Mousumi M. Andersen et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

(2014) Olivia Pagani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathological features and survival outcomes of very young patients with early breast cancer: How much is “very young”?

(2013) Giuseppe Cancello et al.   BREAST

Long-Term Mortality Associated With Oophorectomy Compared With Ovarian Conservation in the Nursesʼ Health Study

(2013) William H. Parker et al.   OBSTETRICS AND GYNECOLOGY

Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease

(2013) Brandon C. Drafts et al.   JACC-Cardiovascular Imaging

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

(2012) E. J. A. Bowles et al.   JNCI-Journal of the National Cancer Institute

Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapy

(2012) Marianne Ulcickas Yood et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial

(2012) David E Newby et al.   Trials

Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis

(2011) Eitan Amir et al.   JNCI-Journal of the National Cancer Institute

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

(2011) Cornelis JH van de Velde et al.   LANCET

Women survive breast cancer but fall victim to heart failure: the shadows and lights of targeted therapy

(2010) Nicola Maurea et al.   Journal of Cardiovascular Medicine

Breast Carcinomas Arising at a Young Age: Unique Biology or a Surrogate for Aggressive Intrinsic Subtypes?

(2010) Carey K. Anders et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer

(2009) Wonshik Han et al.   BREAST CANCER RESEARCH AND TREATMENT

Breast cancer as a global health concern

(2009) Steven S. Coughlin et al.   Cancer Epidemiology

Aortic Stiffness Increases Upon Receipt of Anthracycline Chemotherapy

(2009) Narumol Chaosuwannakit et al.   JOURNAL OF CLINICAL ONCOLOGY

Competing Causes of Death for Women With Breast Cancer and Change Over Time From 1975 to 2003

(2008) Xianglin L. Du et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS